Elephas, a private company developing an oncology imaging diagnostics platform, has raised $55 million in Series C funding. The funding round was led by Venture Investors Health Fund and the State of Wisconsin Investment Board, with participation from other investors including Northpond Ventures and ARCH Ventures. Elephas aims to use the funding to advance its live tumor imaging diagnostic platform, which uses metabolic imaging and live patient biopsies to predict response to immunotherapy. The company is conducting observational clinical trials to demonstrate the correlation between a patient’s clinical response to immunotherapy and data obtained from the Elephas platform.
Elephas Raises $55M: Fueling Future Growth with Series C
Latest from Blog
Arch Venture Partners secures over $3bn for Fund XIII
TLDR: Arch Venture Partners has raised over $3 billion for Fund XIII. Investors in the fund include Alaska Permanent Fund and Rockefeller Brothers Fund. In a recent development, Arch Venture Partners has
Raising Your First Venture Fund: Tips for Success
TLDR: Samir Kaji, a seasoned venture capital professional, shares a six-point plan for raising a venture fund as a first-time fund manager. Key steps include staying focused on a niche, not worrying
Exploring China’s Quantum Computing Breakthrough and VC Trends
TLDR: ONCO stock surged over 80% in pre-market after Altos Venture acquired a stake Chinese low float stocks like DUO rose over 40% in sympathy with large caps Summary: The article discusses
The Blindspot: Venture Capitalists’ Go-To Tool with Fatal Flaw
TLDR: Nader Al-Naji, founder of Bitclout, was arrested for an alleged crypto scam involving VC giant Andreessen Horowitz as a victim. VCs’ pattern matching led them to invest in Al-Naji despite red
Korean startups seek corporate investors in challenging ecosystem climate
TLDR: Korean startups are seeking corporate investors as funding becomes harder to secure. The government in South Korea has relaxed CVC rules to attract more foreign investment. Korean startups are facing a